MedTrace Logo

Erythropoietin And/Or Iron Sucrose For Perioperative Anemia Management In Hip and Knee Arthroplasty

NCT03917394 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 780

Last updated 2019-04-25

No results posted yet for this study

Summary

Perioperative anemia is very common in patients undergoing total hip arthroplasty (THA) and total knee arthroplasty (TKA). This study retrospectively analyzes the use of rHuEPO and iron sucrose in patients undergoing total hip and knee arthroplasty in order to observe the short-term efficacy and safety of rHuEPO and iron sucrose.

Conditions

  • Anemia, Iron Deficiency

Interventions

DRUG

rHuEPO

rHuEPO was administrated daily with 10000 IU or 20000 IU

DRUG

Iron sucrose

Iron sucrose was administrated daily with 100mg or 200mg

Sponsors & Collaborators

  • Peking Union Medical College Hospital

    lead OTHER

Principal Investigators

  • Wei Wang, PhD · Peking Union Medical College Hospital

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-24
Primary Completion
2019-05-30
Completion
2019-09-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03917394 on ClinicalTrials.gov